Thus, despite promising early results with K201 and subsequently S107, it is not clear to which extent an intervention leading to enhanced FKBP12.6 binding to RyR2 may contribute to an overall improvement of heart disease, particularly in larger clinically relevant species (Seidler et al, 2011) or in human heart models studied here. The gene discussed is RYR2; the disease is heart disorder.